Showing results (111-120 of 270) with videos related to
Sort By:
Pageof 27
Current Oncology (Toronto, Ont.)|March 28, 2023
Stage III Non-Small-Cell Lung Cancer: An Overview of Treatment OptionsFrancesco Petrella, Stefania Rizzo, Ilaria Attili, et al.Cancer Treatment Communications|November 25, 2015
Experience with targeted next generation sequencing for the care of lung cancer: insights into promises and limitations of genomic oncology in day-to-day practiceDeepa Rangachari, Paul A VanderLaan, Xiuning Le, et al.Genes|July 29, 2025
Management of MET-Driven Resistance to Osimertinib in EGFR-Mutant Non-Small Cell Lung CancerPanagiotis Agisilaos Angelopoulos, Antonio Passaro, Ilaria Attili, et al.Cell|March 29, 2024
Cancer biomarkers: Emerging trends and clinical implications for personalized treatmentAntonio Passaro, Maise Al Bakir, Emily G Hamilton, et al.Genes|June 27, 2024
The Evolving Scenario of ES-SCLC Management: From Biology to New Cancer TherapeuticsPamela Trillo Aliaga, Ester Del Signore, Valeria Fuorivia, et al.Current Oncology (Toronto, Ont.)|September 27, 2024
Management of Non-Metastatic Non-Small Cell Lung Cancer (NSCLC) with Driver Gene Alterations: An Evolving ScenarioValeria Fuorivia, Ilaria Attili, Carla Corvaja, et al.Cancers|May 5, 2021
Genomic Characterization of Concurrent Alterations in Non-Small Cell Lung Cancer (NSCLC) Harboring Actionable MutationsAntonio Passaro, Ilaria Attili, Alessandra Rappa, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 23, 2020
Dual EGFR-VEGF Pathway Inhibition: A Promising Strategy for Patients With EGFR-Mutant NSCLCXiuning Le, Monique Nilsson, Jonathan Goldman, et al.Lung Cancer (Amsterdam, Netherlands)|February 22, 2015
De novo pulmonary small cell carcinomas and large cell neuroendocrine carcinomas harboring EGFR mutations: Lack of response to EGFR inhibitorsXiuning Le, Neelam V Desai, Adnan Majid, et al.Cancer Letters|March 22, 2023
Potent antitumor activity of ensartinib in MET exon 14 skipping-mutated non-small cell lung cancerYang Xia, Rui Jin, Miao Li, et al.Pageof 27